Perry Fuchs is a Rheumatology/Immunology physician affiliated with The University of Texas Rio Grande Valley. OpenAlex indexes 112 publications with 7,330 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
Telephone
303-394-2828Provider last certified this registry record 13 Sept 2023.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- Novartis Pharmaceuticals CorporationProgram year202512 payments
- Amgen Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
72.4%Interleukin-6 Receptor Antagonist39.2%Tocilizumab100%Part B, office-administered≥20 patientsTNF inhibitor15.4%Golimumab63%Infliximab36%Enbrel Sureclick0%Humira(Cf) Pen0%Enbrel0%Part D + Part B<11 patients+ 5 more classes in this area
Musculoskeletal
25%Other drugs affecting bone structure and mineralization13.9%Romosozumab-aqqg100%Part B, office-administered≥20 patientsRANK Ligand Inhibitor11%Denosumab100%Part B, office-administered≥97 patients+ 1 more class in this area
Dermatology
1.7%Corticosteroid1.7%Methylprednisolone acetate57%Methylprednisolone sodium succinate36%Triamcinolone acetonide6%Methylprednisolone1%Part D + Part B<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Wondwossen Tekle, MD
The University of Texas Rio Grande Valley
Ihsan Salloum, MD
The University of Texas Rio Grande Valley
Everardo Cobos, MD
The University of Texas Rio Grande Valley
Adolfo Kaplan, MD
The University of Texas Rio Grande Valley
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”